Literature DB >> 3805282

Molecular heterogeneity of a lymphocyte glycoprotein in immunodeficient patients.

D Reisinger, R Parkman.   

Abstract

Previous evaluation of lymphocytes taken from patients with Wiskott-Aldrich syndrome (WAS) and other X-linked immunodeficiencies has revealed deficiencies of a lymphocyte sialoglycoprotein with a relative molecular mass of 115 kD (designated gpL-115) found in normal lymphocytes. The development of monoclonal antibodies to gpL-115 has permitted the detection of molecular heterogeneity in gpL-115 from the lymphocytes of immunodeficient patients. When lymphocytes from normal individuals were analyzed by immunoblotting, gpL-115 with only a single molecular species (115 kD) was detected. Lymphocytes from 17 immunodeficient patients were analyzed after overnight incubation. Two patients had no gpL-115 with an Mr of 115 kD, but gpL-115 with an Mr of either 95 or 135 kD was detected. Nine patients had gpL-115 with Mr equally of 95 and 115 Kd. Other patients exhibited gpL-115 with combinations of 95, 115, and 135 kD. The heterogeneity of the degraded gpL-115 suggests that WAS and other X-linked immunodeficiencies are due to a series of abnormalities, all of which involve gpL-115, and may explain the clinical heterogeneity of the diseases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3805282      PMCID: PMC424136          DOI: 10.1172/JCI112852

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  9 in total

1.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  Immune abnormalities in patients lacking a lymphocyte surface glycoprotein.

Authors:  R Parkman; E Remold-O'Donnell; L Cairns; J M Rappeport; M Cowan; A Ammann; D Kenney; N Potter; F S Rosen
Journal:  Clin Immunol Immunopathol       Date:  1984-12

3.  Identification of a glycophorin-like molecule at the cell surface of rat thymocytes.

Authors:  W R Brown; A N Barclay; C A Sunderland; A F Williams
Journal:  Nature       Date:  1981-02-05       Impact factor: 49.962

4.  Surface protein abnormalities in lymphocytes and platelets from patients with Wiskott-Aldrich syndrome.

Authors:  R Parkman; E Remold-O'Donnell; D M Kenney; S Perrine; F S Rosen
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

5.  Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.

Authors:  R Parkman; J Rappeport; R Geha; J Belli; R Cassady; R Levey; D G Nathan; F S Rosen
Journal:  N Engl J Med       Date:  1978-04-27       Impact factor: 91.245

6.  The large sialoglycoprotein of human lymphocytes. II. Biochemical features.

Authors:  B Axelsson; S Hammarström; J Finne; P Perlmann
Journal:  Eur J Immunol       Date:  1985-05       Impact factor: 5.532

7.  The large sialoglycoprotein of human lymphocytes. I. Distribution on T and B lineage cells as revealed by a monospecific chicken antibody.

Authors:  B Axelsson; S Hammarström; E S Robertsson; P Aman; P Perlmann; H Mellstedt
Journal:  Eur J Immunol       Date:  1985-05       Impact factor: 5.532

8.  Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome.

Authors:  D Kenney; L Cairns; E Remold-O'Donnell; J Peterson; F S Rosen; R Parkman
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

9.  Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome.

Authors:  E Remold-O'Donnell; D M Kenney; R Parkman; L Cairns; B Savage; F S Rosen
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

  9 in total
  8 in total

Review 1.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

2.  Purification of two glycoproteins expressing beta 1-6 branched Asn-linked oligosaccharides from metastatic tumour cells.

Authors:  S Laferte; J W Dennis
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

3.  Differential epitope expression of Ly-48 (mouse leukosialin).

Authors:  C M Baecher-Allan; J D Kemp; K S Dorfman; R K Barth; J G Frelinger
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

4.  Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome.

Authors:  F Piller; F Le Deist; K I Weinberg; R Parkman; M Fukuda
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

5.  T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome.

Authors:  I J Molina; D M Kenney; F S Rosen; E Remold-O'Donnell
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

6.  Human immunodeficiency virus type 1-infected individuals make autoantibodies that bind to CD43 on normal thymic lymphocytes.

Authors:  B Ardman; M A Sikorski; M Settles; D E Staunton
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

7.  Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line.

Authors:  J C Lefebvre; V Giordanengo; M Limouse; A Doglio; M Cucchiarini; F Monpoux; R Mariani; J F Peyron
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

8.  Absence of WASp Enhances Hematopoietic and Megakaryocytic Differentiation in a Human Embryonic Stem Cell Model.

Authors:  Miguel G Toscano; Pilar Muñoz; Almudena Sánchez-Gilabert; Marién Cobo; Karim Benabdellah; Per Anderson; Verónica Ramos-Mejía; Pedro J Real; Olaf Neth; Agueda Molinos-Quintana; Philip D Gregory; Michael C Holmes; Francisco Martin
Journal:  Mol Ther       Date:  2015-10-27       Impact factor: 11.454

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.